A citation-based method for searching scientific literature

Masayuki Sekine, Koji Nishino, Takayuki Enomoto. Cancers (Basel) 2021
Times Cited: 3







List of co-cited articles
19 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for a genotype-phenotype correlation.
S A Gayther, W Warren, S Mazoyer, P A Russell, P A Harrington, M Chiano, S Seal, R Hamoudi, E J van Rensburg, A M Dunning,[...]. Nat Genet 1995
431
66

Analysis of clinical characteristics of breast cancer patients with the Japanese founder mutation BRCA1 L63X.
Reiko Yoshida, Chie Watanabe, Shiro Yokoyama, Mayuko Inuzuka, Junko Yotsumoto, Masami Arai, Seigo Nakamura. Oncotarget 2019
6
66

BRCA1 and BRCA2 mutations in the ovarian cancer population across race and ethnicity: special reference to Asia.
Santhanam Shanmughapriya, Vasanthi Nachiappan, Kalimuthusamy Natarajaseenivasan. Oncology 2013
21
66

Breast and ovarian cancer risks to carriers of the BRCA1 5382insC and 185delAG and BRCA2 6174delT mutations: a combined analysis of 22 population based studies.
A C Antoniou, P D P Pharoah, S Narod, H A Risch, J E Eyfjord, J L Hopper, H Olsson, O Johannsson, A Borg, B Pasini,[...]. J Med Genet 2005
109
66

A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.
Y Miki, J Swensen, D Shattuck-Eidens, P A Futreal, K Harshman, S Tavtigian, Q Liu, C Cochran, L M Bennett, W Ding. Science 1994
66

Cancer variation associated with the position of the mutation in the BRCA2 gene.
Jan Lubinski, Catherine M Phelan, Parviz Ghadirian, Henry T Lynch, Judy Garber, Barbara Weber, Nadine Tung, Douglas Horsman, Claudine Isaacs, Alvaro N A Monteiro,[...]. Fam Cancer 2004
73
66

Localization of a novel susceptibility gene for familial ovarian cancer to chromosome 3p22-p25.
M Sekine, H Nagata, S Tsuji, Y Hirai, S Fujimoto, M Hatae, I Kobayashi, T Fujii, I Nagata, K Ushijima,[...]. Hum Mol Genet 2001
19
66

Variation of risks of breast and ovarian cancer associated with different germline mutations of the BRCA2 gene.
S A Gayther, J Mangion, P Russell, S Seal, R Barfoot, B A Ponder, M R Stratton, D Easton. Nat Genet 1997
340
66

Precision medicine for hereditary tumors in gynecologic malignancies.
Masayuki Sekine, Takayuki Enomoto. J Obstet Gynaecol Res 2021
3
66

Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer.
Timothy R Rebbeck, Nandita Mitra, Fei Wan, Olga M Sinilnikova, Sue Healey, Lesley McGuffog, Sylvie Mazoyer, Georgia Chenevix-Trench, Douglas F Easton, Antonis C Antoniou,[...]. JAMA 2015
273
66

Ovarian cancer risk in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations.
Jaya M Satagopan, Jeff Boyd, Noah D Kauff, Mark Robson, Lauren Scheuer, Steven Narod, Kenneth Offit. Clin Cancer Res 2002
113
66

Association of gBRCA1/2 mutation locations with ovarian cancer risk in Japanese patients from the CHARLOTTE study.
Kosuke Yoshihara, Takayuki Enomoto, Daisuke Aoki, Yoh Watanabe, Junzo Kigawa, Nobuhiro Takeshima, Hyoe Inomata, Kana Hattori, Masahisa Jinushi, Hitoshi Tsuda,[...]. Cancer Sci 2020
4
66

Mutational analysis of BRCA1 and BRCA2 and clinicopathologic analysis of ovarian cancer in 82 ovarian cancer families: two common founder mutations of BRCA1 in Japanese population.
M Sekine, H Nagata, S Tsuji, Y Hirai, S Fujimoto, M Hatae, I Kobayashi, T Fujii, I Nagata, K Ushijima,[...]. Clin Cancer Res 2001
64
66

Inherited susceptibility to common cancers.
William D Foulkes. N Engl J Med 2008
327
66

Phase II study of single-agent cabozantinib in patients with recurrent clear cell ovarian, primary peritoneal or fallopian tube cancer (NRG-GY001).
Panagiotis A Konstantinopoulos, William E Brady, John Farley, Amy Armstrong, Denise S Uyar, David M Gershenson. Gynecol Oncol 2018
27
66

Mutations in context: implications of BRCA testing in diverse populations.
Gabriela E S Felix, Yonglan Zheng, Olufunmilayo I Olopade. Fam Cancer 2018
15
66

Variation in BRCA1 cancer risks by mutation position.
Deborah Thompson, Douglas Easton. Cancer Epidemiol Biomarkers Prev 2002
152
66

Prophylactic salpingo-oophorectomy in BRCA1 mutation carriers and postoperative incidence of peritoneal and breast cancers.
Janusz Menkiszak, Anita Chudecka-Głaz, Jacek Gronwald, Aneta Cymbaluk-Płoska, Aleksander Celewicz, Maria Świniarska, Małgorzata Wężowska, Ryszard Bedner, Dorota Zielińska, Paulina Tarnowska,[...]. J Ovarian Res 2016
7
66

Risk-reducing salpingo-oophorectomy for the prevention of BRCA1- and BRCA2-associated breast and gynecologic cancer: a multicenter, prospective study.
Noah D Kauff, Susan M Domchek, Tara M Friebel, Mark E Robson, Johanna Lee, Judy E Garber, Claudine Isaacs, D Gareth Evans, Henry Lynch, Rosalind A Eeles,[...]. J Clin Oncol 2008
365
66

Prevalence and clinical correlations of BRCA1/BRCA2 unclassified variant carriers among unselected primary ovarian cancer cases - preliminary report.
Ewa J Majdak, Geertruida H De Bock, Izabela Brozek, Magdalena Perkowska, Karolina Ochman, Jaroslaw Debniak, Tomasz Milczek, Cees J Cornelisse, J Jassem, Janusz Emerich,[...]. Eur J Cancer 2005
19
33

Inherited Mutations in Women With Ovarian Carcinoma.
Barbara M Norquist, Maria I Harrell, Mark F Brady, Tom Walsh, Ming K Lee, Suleyman Gulsuner, Sarah S Bernards, Silvia Casadei, Qian Yi, Robert A Burger,[...]. JAMA Oncol 2016
377
33

The association of BRCA1 and BRCA2 mutations with prostate cancer risk, frequency, and mortality: A meta-analysis.
Mok Oh, Nasser Alkhushaym, Saad Fallatah, Abdulhamid Althagafi, Rana Aljadeed, Yazed Alsowaida, Joanne Jeter, Jennifer R Martin, Hani M Babiker, Ali McBride,[...]. Prostate 2019
38
33

Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE.
Nasim Mavaddat, Susan Peock, Debra Frost, Steve Ellis, Radka Platte, Elena Fineberg, D Gareth Evans, Louise Izatt, Rosalind A Eeles, Julian Adlard,[...]. J Natl Cancer Inst 2013
520
33

Ovarian cancer in BRCA1/2 mutation carriers: The impact of mutation position and family history on the cancer risk.
Natalia Teixeira, Marian J E Mourits, Janet R Vos, Dorina M van der Kolk, Liesbeth Jansen, Jan C Oosterwijk, Geertruida H de Bock. Maturitas 2015
4
33

Analysis of BRCA1 and BRCA2 genes in Spanish breast/ovarian cancer patients: a high proportion of mutations unique to Spain and evidence of founder effects.
Orland Díez, Ana Osorio, Mercedes Durán, José Ignacio Martinez-Ferrandis, Miguel de la Hoya, Raquel Salazar, Ana Vega, Berta Campos, Raquel Rodríguez-López, Eladio Velasco,[...]. Hum Mutat 2003
135
33

BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers.
Huong D Meeks, Honglin Song, Kyriaki Michailidou, Manjeet K Bolla, Joe Dennis, Qin Wang, Daniel Barrowdale, Debra Frost, Lesley McGuffog, Steve Ellis,[...]. J Natl Cancer Inst 2015
65
33

BRCA mutated pancreatic cancer: A change is coming.
Michael N Rosen, Rachel A Goodwin, Michael M Vickers. World J Gastroenterol 2021
5
33

Frequency of mutations in individuals with breast cancer referred for BRCA1 and BRCA2 testing using next-generation sequencing with a 25-gene panel.
Nadine Tung, Chiara Battelli, Brian Allen, Rajesh Kaldate, Satish Bhatnagar, Karla Bowles, Kirsten Timms, Judy E Garber, Christina Herold, Leif Ellisen,[...]. Cancer 2015
276
33

Is uterine papillary serous adenocarcinoma a manifestation of the hereditary breast-ovarian cancer syndrome?
R Goshen, W Chu, L Elit, T Pal, J Hakimi, I Ackerman, A Fyles, M Mitchell, S A Narod. Gynecol Oncol 2000
97
33

The first Japanese nationwide multicenter study of BRCA mutation testing in ovarian cancer: CHARacterizing the cross-sectionaL approach to Ovarian cancer geneTic TEsting of BRCA (CHARLOTTE).
Takayuki Enomoto, Daisuke Aoki, Kana Hattori, Masahisa Jinushi, Junzo Kigawa, Nobuhiro Takeshima, Hitoshi Tsuda, Yoh Watanabe, Kosuke Yoshihara, Toru Sugiyama. Int J Gynecol Cancer 2019
33
33

BRCA1 and BRCA2 mutation prevalence and clinical characteristics of a population-based series of ovarian cancer cases from Denmark.
Marie Soegaard, Susanne Kruger Kjaer, Mark Cox, Eva Wozniak, Estrid Høgdall, Claus Høgdall, Jan Blaakaer, Ian J Jacobs, Simon A Gayther, Susan J Ramus. Clin Cancer Res 2008
75
33

Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers.
Karoline B Kuchenbaecker, John L Hopper, Daniel R Barnes, Kelly-Anne Phillips, Thea M Mooij, Marie-José Roos-Blom, Sarah Jervis, Flora E van Leeuwen, Roger L Milne, Nadine Andrieu,[...]. JAMA 2017
994
33

BRCA1 genomic deletions are major founder mutations in Dutch breast cancer patients.
A Petrij-Bosch, T Peelen, M van Vliet, R van Eijk, R Olmer, M Drüsedau, F B Hogervorst, S Hageman, P J Arts, M J Ligtenberg,[...]. Nat Genet 1997
348
33

Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario, Canada.
Harvey A Risch, John R McLaughlin, David E C Cole, Barry Rosen, Linda Bradley, Isabel Fan, James Tang, Song Li, Shiyu Zhang, Patricia A Shaw,[...]. J Natl Cancer Inst 2006
453
33

Ovarian cancer: epidemiology and risk factors.
Carlo La Vecchia. Eur J Cancer Prev 2017
127
33

The risk of endometrial cancer in women with BRCA1 and BRCA2 mutations. A prospective study.
Mario E Beiner, Amy Finch, Barry Rosen, Jan Lubinski, Pal Moller, Parviz Ghadirian, Henry T Lynch, Eitan Friedman, Ping Sun, Steven A Narod. Gynecol Oncol 2007
84
33

A study of over 35,000 women with breast cancer tested with a 25-gene panel of hereditary cancer genes.
Saundra S Buys, John F Sandbach, Amanda Gammon, Gayle Patel, John Kidd, Krystal L Brown, Lavania Sharma, Jennifer Saam, Johnathan Lancaster, Mary B Daly. Cancer 2017
201
33

Predictors of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers.
K Metcalfe, S Gershman, H T Lynch, P Ghadirian, N Tung, C Kim-Sing, O I Olopade, S Domchek, J McLennan, A Eisen,[...]. Br J Cancer 2011
123
33

BRCA1 and BRCA2 mutations and clinical interpretation in 398 ovarian cancer patients: comparison with breast cancer variants in a similar population.
Florencia C Cardoso, Susana Goncalves, Pablo G Mele, Natalia C Liria, Leonardo Sganga, Ignacio Diaz Perez, Ernesto J Podesta, Angela R Solano. Hum Genomics 2018
12
33

Cancer Incidence in BRCA1 mutation carriers.
Deborah Thompson, Douglas F Easton. J Natl Cancer Inst 2002
744
33

Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.
Mary B Daly, Tuya Pal, Michael P Berry, Saundra S Buys, Patricia Dickson, Susan M Domchek, Ahmed Elkhanany, Susan Friedman, Michael Goggins, Mollie L Hutton,[...]. J Natl Compr Canc Netw 2021
110
33

Prevalence of deleterious germline variants in risk genes including BRCA1/2 in consecutive ovarian cancer patients (AGO-TR-1).
Philipp Harter, Jan Hauke, Florian Heitz, Alexander Reuss, Stefan Kommoss, Frederik Marmé, André Heimbach, Katharina Prieske, Lisa Richters, Alexander Burges,[...]. PLoS One 2017
54
33

Risk of breast cancer in male BRCA2 carriers.
D G R Evans, I Susnerwala, J Dawson, E Woodward, E R Maher, F Lalloo. J Med Genet 2010
63
33

Reclassification of BRCA1 and BRCA2 variants found in ovarian epithelial, fallopian tube, and primary peritoneal cancers.
Hyeong In Ha, Jin Sun Ryu, Hyoeun Shim, Sun Young Kong, Myong Cheol Lim. J Gynecol Oncol 2020
3
33

Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer.
H A Risch, J R McLaughlin, D E Cole, B Rosen, L Bradley, E Kwan, E Jack, D J Vesprini, G Kuperstein, J L Abrahamson,[...]. Am J Hum Genet 2001
723
33

The Icelandic founder mutation BRCA2 999del5: analysis of expression.
Evgenia K Mikaelsdottir, Sigridur Valgeirsdottir, Jorunn E Eyfjord, Thorunn Rafnar. Breast Cancer Res 2004
37
33

One in 10 ovarian cancer patients carry germ line BRCA1 or BRCA2 mutations: results of a prospective study in Southern Sweden.
S Malander, M Ridderheim, A Måsbäck, N Loman, U Kristoffersson, H Olsson, M Nilbert, A Borg. Eur J Cancer 2004
69
33

Decreased prostate cancer-specific survival of men with BRCA2 mutations from multiple breast cancer families.
Heather Thorne, Amber J Willems, Eveline Niedermayr, Ivan M Y Hoh, Jason Li, David Clouston, Gillian Mitchell, Stephen Fox, John L Hopper, Damien Bolton. Cancer Prev Res (Phila) 2011
78
33

Treatment of endometriosis in different ethnic populations: a meta-analysis of two clinical trials.
Christoph Gerlinger, Thomas Faustmann, Jeffrey J Hassall, Christian Seitz. BMC Womens Health 2012
18
33

Multigene Panels to Evaluate Hereditary Cancer Risk: Reckless or Relevant?
Michael J Hall, Elias Obeid, Mary B Daly. J Clin Oncol 2016
10
33


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.